A run-in phase clinical study for intravesical administration of durvalumab in patients with high-risk, non-muscle-invasive bladder cancer (NMIBC)

• A. Papatsoris,
• C. Fragkoulis,
• E. Fragkiadis,
• A. Pinitas,
• K. Tzannis,
• N. Gavalas,
• K. Stravodimos,
• K. Ntoumas,
• D. Mitropoulos,
• K. Constantinides,
• E. Giannopoulou,
• A. Bamias,
• C. Deliveliotis

Affiliations

A. Papatsoris

C. Fragkoulis

E. Fragkiadis

A. Pinitas

K. Tzannis

N. Gavalas

K. Stravodimos

K. Ntoumas

D. Mitropoulos

K. Constantinides

E. Giannopoulou

A. Bamias

C. Deliveliotis